Related Experiment Videos
Renal cryoablation: outcome at 3 years
Inderbir S Gill1, Erick M Remer, Waleed A Hasan
1Section of Laparoscopic and Minimally Invasive Surgery, Glickman Urological Institute and Department of Radiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA. gilli@ccf.org
The Journal of Urology
|May 10, 2005
Summary
Laparoscopic renal cryoablation shows encouraging 3-year oncological outcomes for kidney tumors. This minimally invasive technique offers a high cancer-specific survival rate with minimal complications.
Area of Science:
- Urology
- Oncology
- Minimally Invasive Surgery
Background:
- Renal cryoablation is a minimally invasive nephron-sparing treatment option for kidney tumors.
- Evaluating intermediate-term oncological outcomes is crucial for establishing its role in treatment paradigms.
Purpose of the Study:
- To report intermediate-term oncological follow-up data for patients treated with laparoscopic renal cryoablation.
- To assess the safety and efficacy of this procedure over a 3-year period.
Main Methods:
- Prospective follow-up of 56 patients who underwent laparoscopic renal cryoablation.
- Serial magnetic resonance imaging (MRI) and CT-guided needle biopsies were used for monitoring.
- Data collection included cryolesion size, tumor recurrence, and oncological outcomes.
Main Results:
- A significant reduction in cryolesion size was observed over 3 years, with 38% disappearing completely by MRI.
- The 3-year cancer-specific survival rate was 98% for patients with unilateral, sporadic renal tumors.
- No cases of open conversion, kidney loss, urinary fistula, dialysis, or local recurrence were reported.
Conclusions:
- Laparoscopic renal cryoablation demonstrates encouraging 3-year oncological outcomes.
- Further long-term (5-year) data are needed to fully define its role among nephron-sparing options.